We are live on ! Find out more
PAHC icon

Phibro Animal Health

172 hedge funds and large institutions have $436M invested in Phibro Animal Health in 2024 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 66 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 18

83% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 36

17% more funds holding

Funds holding: 147172 (+25)

2.33% more ownership

Funds ownership: 99.74%102.07% (+2.3%)

5% less capital invested

Capital invested by funds: $457M → $436M (-$20.9M)

Holders
172
Holders Change
+25
Holders Change %
+17.01%
% of All Funds
2.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
66
Reduced
36
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$1.17M -$72.2K -3,120 -5%
BCM
52
Bridgeway Capital Management
Texas
$1.16M +$1.27M +55,000 New
Qube Research & Technologies (QRT)
53
Qube Research & Technologies (QRT)
United Kingdom
$1.14M +$1.26M +54,323 New
CSS
54
Cubist Systematic Strategies
Connecticut
$1.12M +$1.23M +53,307 New
Raymond James Financial
55
Raymond James Financial
Florida
$1.1M +$1.21M +52,503 New
ZIM
56
Zacks Investment Management
Illinois
$1.1M +$927K +40,064 +330%
Public Sector Pension Investment Board (PSP Investments)
57
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.07M +$179K +7,751 +18%
VIA
58
Virtus Investment Advisers
Connecticut
$1.04M +$582K +25,160 +103%
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$1.04M +$298K +12,890 +35%
IQI
60
Integrated Quantitative Investments
Washington
$1.03M +$1.13M +48,941 New
WAM
61
Wakefield Asset Management
Colorado
$1.02M +$1.12M +48,570 New
KK
62
KLP Kapitalforvaltning
Norway
$939K +$1.03M +44,700 New
Swiss National Bank
63
Swiss National Bank
Switzerland
$842K
Citigroup
64
Citigroup
New York
$827K -$40.2K -1,738 -4%
II
65
Inspire Investing
Idaho
$791K +$872K +37,670 New
CCIA
66
Campbell & Co Investment Adviser
Maryland
$727K +$15.4K +665 +2%
SGI
67
Summit Global Investments
Utah
$571K +$629K +27,181 New
SO
68
STRS Ohio
Ohio
$567K +$625K +27,000 New
SGAM
69
Smith Group Asset Management
Texas
$541K +$596K +25,775 New
Los Angeles Capital Management
70
Los Angeles Capital Management
California
$505K +$11.6K +503 +2%
Man Group
71
Man Group
United Kingdom
$501K +$551K +23,836 New
Federated Hermes
72
Federated Hermes
Pennsylvania
$492K +$528K +22,800 +3,535%
Mackenzie Financial
73
Mackenzie Financial
Ontario, Canada
$478K +$526K +22,749 New
VOYA Investment Management
74
VOYA Investment Management
Georgia
$464K -$23.9K -1,034 -4%
Franklin Resources
75
Franklin Resources
California
$459K +$949 +41 +0.2%

PAHC Hedge Fund Activity: Q4 2024 in Review

172 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2024, worth a combined $436M — down 4.6% from $457M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new PAHC positions and 18 closed out — a net gain of 26 holders — while 66 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $5M. The largest seller was Brandes Investment Partners, cutting an estimated $19M.

  • 172 institutional investors held Phibro Animal Health (PAHC) as of Q4 2024, up from 147 in Q3 2024.
  • Funds reported $436M of Phibro Animal Health stock for Q4 2024, down 4.6% quarter-over-quarter.
  • 44 funds opened new Phibro Animal Health positions in Q4 2024 and 18 closed out, a net change of +26 holders.
  • The largest Phibro Animal Health buyer in Q4 2024 was BlackRock, an estimated $5M added.
  • The largest Phibro Animal Health seller in Q4 2024 was Brandes Investment Partners, an estimated $19M sold.

Based on aggregated 13F filings for Q4 2024.